Geron reported $551.9M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 247.94B 20.06B Nov/2026
Bio Techne USD 11.44B 79M Nov/2026
Cassava Sciences USD 58M 24M Jun/2026
Cytokinetics USD 7.51B 1.66B Nov/2026
Exelixis USD 19.82B 5.34B Nov/2026
Genmab DKK 17.1B 88.06B Jun/2026
Geron USD 653M 137M Nov/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Incyte USD 24.6B 1.95B Sep/2026
MacroGenics USD 151M 143M Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Novavax USD 1.09B 316M Dec/2025